
Company valuation, historical trends, and peer comparisons.
According to Lonza Group AG’s latest financial reports and current stock price. The company's current Enterprise Value is 49.89B. This represents a change of 18.42% compared to the average of 42.13B of the last 4 quarters.
The mean historical Enterprise Value of Lonza Group AG over the last ten years is 33.35B. The current 49.89B Enterprise Value has changed 49.61% with respect to the historical average. Over the past ten years (40 quarters), LZAGY's Enterprise Value was at its highest in in the December 2021 quarter at 57.72B. The Enterprise Value was at its lowest in in the June 2012 quarter at 4.66B.
Average
33.35B
Median
32.17B
Minimum
10.22B
Maximum
57.72B
Discovering the peaks and valleys of Lonza Group AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 111.76%
Maximum Annual Enterprise Value = 57.72B
Minimum Annual Increase = -39.57%
Minimum Annual Enterprise Value = 10.22B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 41.48B | -1.64% |
| 2024 | 42.17B | 52.16% |
| 2023 | 27.71B | -20.55% |
| 2022 | 34.88B | -39.57% |
| 2021 | 57.72B | 26.47% |
| 2020 | 45.64B | 54.95% |
| 2019 | 29.45B | 30.60% |
| 2018 | 22.55B | 4.22% |
| 2017 | 21.64B | 111.76% |
| 2016 | 10.22B | 6.26% |
The current Enterprise Value of Lonza Group AG (LZAGY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
37.12B
5-year avg
40.79B
10-year avg
33.35B
Lonza Group AG’s Enterprise Value is less than WuXi Biologics (Cayman) Inc. (163.04B), less than Samsung Biologics Co.,Ltd. (73.58T), greater than Bachem Holding AG (6.28B), less than WuXi AppTec Co., Ltd. (339.44B), greater than Maravai LifeSciences Holdings, Inc. (4.28B), greater than Genscript Biotech Corporation (9.78B), greater than Bio-Techne Corporation (11.45B), greater than Charles River Laboratories International, Inc. (18.37B), greater than West Pharmaceutical Services, Inc. (28.32B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 163.04B | $24.99B | |
| 73.58T | $72.62T | |
| 6.28B | $6.82B | |
| 339.44B | $71.48B | |
| 4.28B | $2.19B | |
| 9.78B | $10.12B | |
| 11.45B | $11.42B | |
| 18.37B | $15.72B | |
| 28.32B | $28.48B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lonza Group AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lonza Group AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Lonza Group AG's Enterprise Value?
What is the highest Enterprise Value for Lonza Group AG (LZAGY)?
What is the 3-year average Enterprise Value for Lonza Group AG (LZAGY)?
What is the 5-year average Enterprise Value for Lonza Group AG (LZAGY)?
How does the current Enterprise Value for Lonza Group AG (LZAGY) compare to its historical average?